Skip to main content
LobbyMap

Novo Nordisk

Pharmaceutical & Health Products · Lobbying Client

C
Influence Score
54/100
Moderate Influence
$11.8M
Total Lobby Spend
5
Policy Issues
8
Lobbyists
2
Revolving Door

Novo Nordisk reported $11.8 million in federal lobbying expenditures (2020-2024) as disclosed in Senate LDA filings. The organization's lobbying activity spans 5 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Dept of Labor
Federal Trade Commission
Dept of Health & Human Services
Dept of the Treasury
Environmental Protection Agency
Dept of the Interior

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2024 Oct-DecFierce Government Relations
PHATAX
3$486K
2024 Jul-SepHogan Lovells
MEDTAXGOV
2$475K
2024 Apr-JunSummit Strategies Government Affairs
GOVPHA
2$480K
2024 Jan-MarCovington & Burling
TAXPHA
3$520K
2023 Oct-DecFranklin Square Group
MEDTAX
2$488K
2023 Jul-SepStewart & Stewart
MEDPHA
2$560K
2023 Apr-JunCassidy & Associates
PHAHCR
2$570K
2023 Jan-MarAkin Gump Strauss Hauer & Feld
TAXHCRGOV+1
4$563K

Novo Nordisk Lobbying FAQ

Novo Nordisk has spent $11.8M on federal lobbying across 5 policy areas. This includes spending on registered lobbyists and direct government contacts.

Novo Nordisk lobbies on 5 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Taxation. These disclosures are filed quarterly with the Senate Office of Public Records.

Novo Nordisk has an Influence Score of 54/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Novo Nordisk employs 8 registered lobbyists, of whom 2 have revolving door connections — meaning they previously held government positions before becoming lobbyists.

Novo Nordisk has contacted 6 government entities as part of their lobbying activities, including Dept of Labor, Federal Trade Commission, Dept of Health & Human Services.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.